(223)RaCl(2) (CHEBI:74895)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	²²³RaCl₂

ChEBI ID	CHEBI:74895

ChEBI ASCII Name	(223)RaCl2

Definition	A radium molecular entity with formula ²²³RaCl₂. Used as as a radiotherapeutic agent for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. An alpha-emitter, radium-223 has a half-life of 11.4 days.

Stars	This entity has been manually annotated by the ChEBI Team.

Supplier Information

Download	Molfile XML SDF

more structures >>

Wikipedia	License

Read full article at Wikipedia

Formula

Cl2[223Ra]

Net Charge

Average Mass

293.920

Monoisotopic Mass

292.95620

InChI

InChI=1S/2ClH.Ra/h2*1H;/q;;+2/p-2/i;;1-3

InChIKey

RWRDJVNMSZYMDV-SIUYXFDKSA-L

SMILES

Cl[223Ra]Cl

Roles Classification
Application(s):	antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. radiopharmaceutical Any pharmaceutical compound containing a radioisotope.

ChEBI Ontology
Outgoing	²²³RaCl₂ (CHEBI:74895) has role antineoplastic agent (CHEBI:35610) ²²³RaCl₂ (CHEBI:74895) has role radiopharmaceutical (CHEBI:35232) ²²³RaCl₂ (CHEBI:74895) is a inorganic chloride (CHEBI:36093) ²²³RaCl₂ (CHEBI:74895) is a isotopically modified compound (CHEBI:139358) ²²³RaCl₂ (CHEBI:74895) is a radium molecular entity (CHEBI:37201)

IUPAC Name

(²²³Ra)radium dichloride

Synonym	Source
Radium-223 dichloride	KEGG DRUG

Brand Name	Source
Xofigo	KEGG DRUG

Last Modified

30 January 2018